Arcus Biosciences, Inc.RCUSNYSE
Loading
Operating Expenses Over TimeStrong
Percentile Rank100
3Y CAGR+16.7%
5Y CAGR+25.3%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+16.7%/yr
vs +57.8%/yr prior
5Y CAGR
+25.3%/yr
Recent deceleration
Acceleration
-41.1pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
3.1x
Strong expansion
Streak
9 yr
Consecutive growthStrong
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $623.00M | +6.0% |
| 2024 | $588.00M | +28.7% |
| 2023 | $457.00M | +16.6% |
| 2022 | $392.00M | +19.1% |
| 2021 | $329.00M | +62.9% |
| 2020 | $202.00M | +94.8% |
| 2019 | $103.71M | +64.1% |
| 2018 | $63.21M | +15.2% |
| 2017 | $54.85M | +201.7% |
| 2016 | $18.18M | - |